Trial intelligence / Profile preview

Apolets vs Plavix in Thai healthy volunteers

NCT02010632Phase 1Completed

Sponsor
Khon Kaen University
Start
Aug 2013
Primary completion
Oct 2014
Countries
1
01

Overview

Phase 1 trial of clopidogrel in myocardial infarction (MI), ischemic stroke and Peripheral Arterial Disease (PAD), sponsored by Khon Kaen University. Primary endpoint: Platelet Inhibition Effect of Clopidogrel at 24 hours. Started Aug 2013; status: completed.

02

Drugs

clopidogrel
03

Conditions

myocardial infarction (MI)ischemic strokePeripheral Arterial Disease (PAD)

Beyond the preview

Go deeper on NCT02010632.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02010632.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call